Back to Archived Journals » Core Evidence » Volume 9

Development of cabozantinib for the treatment of prostate cancer

Total article views   HTML views PDF downloads Totals
12,978 Dovepress* 11,016+ 2,016 13,032
PubMed Central* 1,962 598 2,560
Totals 12,978 2,614 15,592
*Since 23 April 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar